Jan Falcke

Dr. Jan M. Falcke is Director, global Analytical Science and Technology at BioNTech. In his current role, he is leading the Life Cycle Management team which develops and drives the analytical control strategy for late stage and commercial mRNA products. Jan has over 7 years of QC and CMC experience in the development and commercialization of mRNA products with a strong background in analytical development and life cycle management of bioassays. He holds a B.S. degree in Biology and a M.S. in Biochemistry and Molecular Biology from the University of Bremen. He graduated with a Ph.D. in Biology from the Max Planck Institute for Biology at the University of Tübingen.